Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
Home > Our Work > All Publications > 2007


Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

Find an article or report or see all by area, author, or year:


The FDA Animal Efficacy Rule and Biodefense

Gigi Kwik Gronvall, Dennis Trent, Luciana Borio, Robert Brey, Lee Nagao, on behalf of the Alliance for Biosecurity
Date posted:
October 01, 2007
Publication type:

Nat Biotechnol 2007;25(10):1084-1087

Nature Publishing Group
Open access
See also:

Letter on publisher's site: PDF


Your editorial in the June issue draws attention to some of the difficulties encountered by companies developing drugs and vaccines under the umbrella of the Bioshield program. We would like to draw attention to one particular impediment to progress—implementation of the US Food and Drug Administration (FDA) Animal Efficacy Rule (‘the Rule’) to facilitate development of medical countermeasures (that is, medicines and vaccines) for bioterrorism.

Letter on publisher's site: PDF



Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.